News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data Yael L. Maxwell December 13, 2023
News Daily News Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes L.A. McKeown December 08, 2023
News Daily News Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes Michael O'Riordan December 08, 2023
News Daily News Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds Todd Neale December 06, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Conference News AHA 2023 Sudden Cardiac Death Declining Among NCAA Athletes Michael O'Riordan November 15, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
Presentation TCT 2023 Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i Presenter: Eldrin Lewis October 26, 2023
Presentation TCT 2023 Lipoprotein(a): Why Measure and What to Do? Presenter: Sotirios Tsimikas October 26, 2023
Presentation TCT 2023 Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid Presenter: Karol Watson October 26, 2023
Presentation TCT 2023 Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For? Presenter: Amit Khera October 26, 2023
Presentation TCT 2023 Secondary Prevention Case: Complex PCI in Stable Patient (No Prior MI) Presenter: Lauren Ranard October 26, 2023
Presentation TCT 2023 Current Trials Addressing Early and Aggressive Secondary Prevention Presenter: Marc Bonaca October 26, 2023
Presentation TCT 2023 Update on Current Treatment Targets for Secondary Prevention Presenter: Dominick Angiolillo October 26, 2023
Presentation TCT 2023 Secondary Prevention Needs to Be Addressed in the Cath Lab! Presenter: Ajay Kirtane October 26, 2023
Presentation TCT 2023 TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial Presenter: Minju Han October 25, 2023
News Daily News Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals Yael L. Maxwell October 19, 2023